References
- Phan LT, Nguyen TV, Luong QC, et al. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med. 2020. doi:10.1056/NEJMc2001272.
- Zhu N, Zhang D, Wang W, et al., China Novel Coronavirus I, Research T. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020. doi:10.1056/NEJMoa2001017.
- Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020. doi:10.1016/S0140-6736(20)30154-9.
- Chan JF, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9:221–236. doi: 10.1080/22221751.2020.1719902
- Jiang S, Du L, Shi Z. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerg Microbes Infect. 2020;9:275–277. doi: 10.1080/22221751.2020.1723441
- Chen L, Liu W, Zhang Q, et al. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg Microbes Infect. 2020;9:313–319. doi: 10.1080/22221751.2020.1725399
- Tian X, Li C, Huang A, et al. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg Microbes Infect. 2020;9:382–385. doi: 10.1080/22221751.2020.1729069
- Zhang W, Du RH, Li B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9:386–389. doi: 10.1080/22221751.2020.1729071
- Xiao C, Li X, Liu S, et al. HIV-1 did not contribute to the 2019-nCoV genome. Emerg Microbes Infect. 2020;9:378–381. doi: 10.1080/22221751.2020.1727299
- Su L. SARS-CoV-2: no evidence of a laboratory origin. Emerg Microbes Infect. 2020.
- https://cepi.net/get_involved/cfps.
- Haynes BF, Gilbert PB, McElrath MJ, et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med. 2012;366:1275–1286. doi: 10.1056/NEJMoa1113425
- Lu S. Editorial overview: vaccines against challenging viral pathogens and new vaccine technology. Curr Opin Virol. 2014;6:viii–ix. doi: 10.1016/j.coviro.2014.04.006
- Xu J, Qian Y, Wang S, et al. EV71: an emerging infectious disease vaccine target in the Far East? Vaccine. 2010;28:3516–3521. doi: 10.1016/j.vaccine.2010.03.003
- Lu S. EV71 vaccines: a milestone in the history of global vaccine development. Emerg Microbes Infect. 2014;3:e27.